chlorthalidone has been researched along with Kidney Stones in 17 studies
Chlorthalidone: A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.
Excerpt | Relevance | Reference |
---|---|---|
" Our data show that CTL is associated with greater reduction in 24 h UCa compared to similarly dosed HCTZ." | 5.39 | Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones. ( Astor, BC; Gundu, V; Jhagroo, RA; Wolfgram, DF, 2013) |
"We examined the effectiveness of chlorthalidone or magnesium hydroxide in the prevention of recurrent calcium oxalate kidney calculi." | 5.06 | Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. ( Citron, JT; Dolman, LI; Ettinger, B; Livermore, B, 1988) |
"A 60-year-old woman who had been instructed to increase her water intake because of nephrolithiasis developed the syndrome of inappropriate secretion of antidiuretic hormone when treated with chlorthalidone for mild hypertension." | 3.66 | Chlorthalidone-induced syndrome of inappropriate secretion of antidiuretic hormone. ( Barzilai, D; Luboshitzky, R; Tal-Or, Z, 1978) |
"Thiazides are considered to be effective in preventing recurrence of various types of nephrolithiasis, but the optimum dosage has not been established." | 2.66 | [Optimal dosage of chlorthalidone in the prevention of the recurrence of nephrolithiasis is 25 mg per day]. ( Bugnon, JM; Burckhardt, P; Jacquet, AF; Jaeger, P; Portmann, L, 1986) |
"Struvite stones have been associated with significant morbidity and mortality, yet there has not been a report on the medical management of struvite stones in almost 20 years." | 1.43 | Contemporary Management of Struvite Stones Using Combined Endourologic and Medical Treatment: Predictors of Unfavorable Clinical Outcome. ( Ferrandino, MN; Hanna, J; Iqbal, MW; Kuntz, N; Lipkin, ME; Neisius, A; Preminger, GM; Youssef, RF, 2016) |
" Our data show that CTL is associated with greater reduction in 24 h UCa compared to similarly dosed HCTZ." | 1.39 | Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones. ( Astor, BC; Gundu, V; Jhagroo, RA; Wolfgram, DF, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (58.82) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 5 (29.41) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Krieger, NS | 2 |
Asplin, J | 2 |
Granja, I | 2 |
Chen, L | 2 |
Spataru, D | 1 |
Wu, TT | 2 |
Grynpas, M | 2 |
Bushinsky, DA | 4 |
Asplin, JR | 2 |
Ramos, FM | 1 |
Flotteron, C | 1 |
Grynpas, MD | 1 |
Wolfgram, DF | 1 |
Gundu, V | 1 |
Astor, BC | 1 |
Jhagroo, RA | 1 |
Iqbal, MW | 1 |
Youssef, RF | 1 |
Neisius, A | 1 |
Kuntz, N | 1 |
Hanna, J | 1 |
Ferrandino, MN | 1 |
Preminger, GM | 1 |
Lipkin, ME | 1 |
Vigen, R | 1 |
Weideman, RA | 1 |
Reilly, RF | 1 |
Willett, T | 1 |
Culbertson, C | 1 |
Che, SP | 1 |
Raja, KA | 1 |
Schurman, S | 1 |
D'mello, RG | 1 |
Blowey, D | 1 |
Goodyer, P | 1 |
Van Why, S | 1 |
Ploutz-Snyder, RJ | 1 |
Scheinman, SJ | 1 |
Evans, RA | 1 |
Hills, E | 1 |
Wong, SY | 1 |
Wyndham, LE | 1 |
Eade, Y | 1 |
Dunstan, CR | 1 |
Weber, DV | 1 |
Coe, FL | 2 |
Parks, JH | 2 |
Dunn, MS | 1 |
Tembe, V | 1 |
Lockefeer, JH | 1 |
Juttmann, JR | 1 |
Birkenhäger, JC | 2 |
Luboshitzky, R | 1 |
Tal-Or, Z | 1 |
Barzilai, D | 1 |
Ettinger, B | 1 |
Citron, JT | 1 |
Livermore, B | 1 |
Dolman, LI | 1 |
Langman, CB | 1 |
Favus, MJ | 1 |
Jaeger, P | 1 |
Portmann, L | 1 |
Jacquet, AF | 1 |
Bugnon, JM | 1 |
Burckhardt, P | 1 |
Lockefeer, J | 1 |
Bakker, NJ | 1 |
Gursel, E | 1 |
4 trials available for chlorthalidone and Kidney Stones
Article | Year |
---|---|
Responsiveness of hypercalciuria to thiazide in Dent's disease.
Topics: Adolescent; Adult; Amiloride; Calcium; Calcium Oxalate; Child; Chlorthalidone; Chromosomes, Human, X | 2002 |
Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.
Topics: Calcium Oxalate; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Kidn | 1988 |
Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria.
Topics: Adult; Calcium; Calcium Oxalate; Chlorthalidone; Female; Humans; Kidney Calculi; Male; Middle Aged; | 1988 |
[Optimal dosage of chlorthalidone in the prevention of the recurrence of nephrolithiasis is 25 mg per day].
Topics: Calcium; Chlorthalidone; Crystallization; Dose-Response Relationship, Drug; Humans; Kidney Calculi; | 1986 |
13 other studies available for chlorthalidone and Kidney Stones
Article | Year |
---|---|
Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.
Topics: Animals; Calcium; Calcium Oxalate; Chlorthalidone; Hypercalciuria; Kidney Calculi; Potassium Citrate | 2021 |
Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.
Topics: Animals; Bone Density; Calcium Phosphates; Chlorthalidone; Hypercalciuria; Kidney Calculi; Male; Oxa | 2019 |
Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones.
Topics: Calcium; Chlorthalidone; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Calculi; Male; Middl | 2013 |
Contemporary Management of Struvite Stones Using Combined Endourologic and Medical Treatment: Predictors of Unfavorable Clinical Outcome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Calcium Citrate; Chlorthalidone; Comorbidity; | 2016 |
Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Chlorthalidone; Dose- | 2011 |
Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
Topics: Animals; Biomechanical Phenomena; Bone Density; Calcification, Physiologic; Calcium Oxalate; Calcium | 2011 |
Do thiazides prevent recurrent idiopathic renal calcium stones.
Topics: Calcium; Chlorthalidone; Female; Humans; Kidney Calculi; Male; Recurrence | 1981 |
The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
Topics: Adult; Aged; Calcium; Chlorthalidone; Cyclic AMP; Fasting; Female; Humans; Hyperparathyroidism; Kidn | 1984 |
Urinary saturation measurements in calcium nephrolithiasis.
Topics: Calcium; Calcium Oxalate; Chlorthalidone; Female; Humans; Kidney Calculi; Male; Time Factors; Trichl | 1979 |
The effect of long-term chlorthalidone on stone formation and stone growth, intestinal absorption of calcium and secretion of parathyroid hormone in idiopathic hypercalciuria.
Topics: Adult; Calcium; Chlorthalidone; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Kidney Cal | 1977 |
Chlorthalidone-induced syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Chlorthalidone; Female; Humans; Hypertension; Kidney Calculi; Osmolar Concentration; Sodium; Time Fa | 1978 |
[Diuretic treatment of recurrent nephrolithiasis caused by idiopathic hypercalciuria].
Topics: Calcium; Calcium Metabolism Disorders; Chlorthalidone; Humans; Kidney Calculi; Recurrence | 1972 |
Effects of diuretics on renal and intestinal handling of calcium.
Topics: Aged; Calcium; Calcium, Dietary; Chlorthalidone; Female; Humans; Intestinal Absorption; Kidney Calcu | 1970 |